Literature DB >> 14552753

Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells.

Sangtae Oh1, In Howa Jeong, Woon-Seob Shin, Seokjoon Lee.   

Abstract

Thioacetal artemisinin derivatives, in particular, 10alpha-phenylthiodihydroartemisinins (5), 10beta-benzenesulfonyl-9-epi-dihydroartemisinin (9) and 10alpha-mercaptodihydroartemisinin (11), exhibit good growth inhibition activity against HUVEC proliferation at the concentration level of 1 microM.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14552753     DOI： 10.1016/j.bmcl.2003.08.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  6 in total

1.  Stereoselective chlorothiolation of artemisinin-derived C-10 oxa terminal alkynes.

Authors:  Naresh Surineni; Pori Buragohain; Nabin C Barua
Journal:  Mol Divers       Date:  2015-06-19       Impact factor: 2.943

Review 2.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

3.  Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.

Authors:  Alexander M Jacobine; Jennifer R Mazzone; Rachel D Slack; Abhai K Tripathi; David J Sullivan; Gary H Posner
Journal:  J Med Chem       Date:  2012-08-27       Impact factor: 7.446

4.  Fe-MIL-101 exhibits selective cytotoxicity and inhibition of angiogenesis in ovarian cancer cells via downregulation of MMP.

Authors:  Jiaqiang Wang; Daomei Chen; Bin Li; Jiao He; Deliang Duan; Dandan Shao; Minfang Nie
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

5.  Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway.

Authors:  Jiao Zhang; Ling Guo; Xia Zhou; Fengyun Dong; Liqun Li; Zuowang Cheng; Yinghua Xu; Jiyong Liang; Qi Xie; Ju Liu
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

6.  Preparation of parenteral nanocrystal suspensions of etoposide from the excipient free dry state of the drug to enhance in vivo antitumoral properties.

Authors:  Brice Martin; Johanne Seguin; Maxime Annereau; Thomas Fleury; René Lai-Kuen; Giovanni Neri; Anita Lam; Marcel Bally; Nathalie Mignet; Yohann Corvis
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.